• Phone: +256 752 024703
  • Email: info@ambso.org
AMBSO in a Research Partnership with CDC and RHSP to implement a COVID-19 Population Study
Research

AMBSO in a Research Partnership with CDC and RHSP to implement a COVID-19 Population Study

The emergence of a new virus means that, understanding transmission patterns, severity, clinical features and risk factors for infection is often limited at the start of an outbreak. To address these unknowns, Innovative Investigation Protocols have to be put together and implemented for the bigger public health benefit.

With the leadership of Julie R. Harris, PhD, MPH, the Resident Advisor, Uganda Public Health Fellowship Program, Division of Global Health Protection, Centre for Global Health of the U.S. Centres for Disease Control and Prevention, AMBSO has partnered with the Uganda’s Centres for Disease Control (CDC) and the Rakai Health Sciences Program (RHSP) to implement a protocol titled; “SARS CoV-2 Infection, Transmission, and Natural History  of COVID-2019 Among a Population  with High Levels of HIV and Tuberculosis”.

This study has partially been funded by CDC to rapidly and systematically evaluate the impact of HIV, TB, and HIV/TB coinfection on outcomes of COVID-19 disease and also to evaluate the impact of HIV, TB, and HIV/TB coinfection on incidence of (risk for) COVID-19 disease.

 

Data collected from this study will help to characterize key epidemiological features of COVID-19, help understand spread, severity, spectrum of disease, and impact on the community and to inform guidance for application of countermeasures at a population level.  such as case isolation and contact tracing. 

AMBSO’s lead investigator on this study is Dr. Noah Kiwanuka.